Global /Vietnam /Healthcare /Drug Manufacturers - General /IMP

Imexpharm Corp.

IMP

• HOSE: IMP • Delayed

50,800VND 6.9%

1.93 USD

As of 5 June 2026, Imexpharm Corp. has a market cap of $296.99M USD, ranking #18649 globally and #130 in Vietnam. It ranks #1687 in the Healthcare sector, and #614 in the Drug Manufacturers - General industry.

Global Rank

18649

Country Rank

130

Sector Rank

1687

Industry Rank

614

Key Stats

Market Cap

$296.99MUSD

7.82T VND

Enterprise Value

$287.16MUSD

7.56T VND

Revenue (TTM)

$90.85MUSD

2.39T VND

EBITDA (TTM)

$21.59MUSD

568.43B VND

Net Income (TTM)

$11.81MUSD

311.12B VND

EBITDA Margin

24%

Profit Margin

15%

PE Ratio

25.1

Forward PE

21.3

PS Ratio

3.3

PB Ratio

3.3

EV/EBITDA

13.3

Company Profile

Country (HQ)

Vietnam

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Dao Tran open_in_new

Employees

1,444

Founded

1997

Website

imexpharm.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
6.9%	-14%	-13%	-12%	-3%	-9.5%	10%	111%	51%

Upcoming Earnings

Earnings Date

Fri, Jul 17

News

Markets

Exchange	Ticker	Price	Quotes
Ho Chi Minh Stock Exchange (HOSE) MIC: XSTC PRIMARY	IMP CTCP Dược phẩm Imexpharm ISIN: VN000000IMP0 Shares Out.: Shares Outstanding: 154.009M¹ Shares Float: 45.363M² TV: TradingView: HOSE: IMP SA: Stock Analysis: HOSE: IMP YF: Yahoo Finance: IMP.VN GF: Google Finance: HOSE: IMP BA: Barron's: IMP MS: Morningstar: XSTC: IMP	50,800 VND	TV: TradingView: HOSE: IMP SA: Stock Analysis: HOSE: IMP YF: Yahoo Finance: IMP.VN GF: Google Finance: HOSE: IMP BA: Barron's: IMP MS: Morningstar: XSTC: IMP

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Imexpharm Corp.

Imexpharm Corporation operates as a pharmaceutical company in Vietnam. The company’s products include injectable antibiotics, oral antibiotics, cardiovascular, ophthalmology, musculoskeletal system, analgesic - anti-inflammatory - antipyretics, respiratory system, antihistamines and anti-allergy, central nervous system, digestive system, diabetes, anti-parasitic, external drugs, vitamins and minerals, and supplements. It is also involved in the import and export. Imexpharm Corporation was founded in 1997 and is headquartered in Cao Lãnh, Vietnam.

Similar Companies

Industry: Drug Manufacturers - General (Vietnam)

Name	Market Cap (USD) diff.	PE	Country
DHG Pharmaceutical JSC HOSE: DHG	$496.31M 13.07T VND 67%	15.0	Vietnam
Ha Tay Pharmaceutical JSC HNX: DHT	$244.11M 6.43T VND -18%	110.1	Vietnam
Binh Dinh Pharmaceutical and Medical Equipment JSC HOSE: DBD	$178.98M 4.72T VND -40%	18.8	Vietnam
Cuu Long Pharmaceutical JSC HOSE: DCL	$103.42M 2.72T VND -65%	139.7	Vietnam
Domesco Medical Import - Export Joint-Stock Corp. HOSE: DMC	$76.46M 2.01T VND -74%	11.6	Vietnam
OPC Pharmaceutical JSC HOSE: OPC	$55.19M 1.45T VND -81%	14.8	Vietnam

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 256K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 184K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 121K%	97.4	United States
Roche Holding AG SIX: RO	$323.4B 256.25B CHF 109K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.25B 215.59B GBP 97K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$276.26B 218.9B CHF 93K%	20.5	Switzerland

chevron_leftBack